Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,575 USD | +1,89% | -2,12% | -19,26% |
Vakgebied
Aantal werknemers: 586
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Antibodies
100,0
%
| 485 | 100,0 % | 38 | 100,0 % | -92,17% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
94,7
%
| 484 | 99,8 % | 36 | 94,7 % | -92,57% |
United States
5,3
%
| 1 | 0,2 % | 2 | 5,3 % | +66,67% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 39 | 08-11-12 | |
Founder | - | 08-11-12 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 08-11-12 |
Andrew Booth
DFI | Director of Finance/CFO | 51 | 01-06-16 |
Tryn Stimart
CMP | Compliance Officer | 54 | 01-08-19 |
Dylan Neid
CTO | Chief Tech/Sci/R&D Officer | - | - |
Melanie Solomon
IRC | Investor Relations Contact | - | - |
Graham Craig
PRN | Corporate Officer/Principal | - | - |
Neil Aubuchon
PRN | Corporate Officer/Principal | 54 | 02-12-21 |
Dani Sidik
AUD | Comptroller/Controller/Auditor | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 01-11-20 |
Michael Hayden
BRD | Director/Board Member | 72 | 01-10-19 |
Andrew Lo
BRD | Director/Board Member | 63 | 07-12-21 |
Andrew Booth
DFI | Director of Finance/CFO | 51 | 01-06-16 |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 08-11-12 |
Founder | 39 | 08-11-12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 292 782 152 | 208 414 732 ( 71,18 %) | 0 | 71,18 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,26% | 1,31 mld. | |
+8,12% | 45,97 mld. | |
+53,69% | 43,93 mld. | |
+9,59% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,14% | 27,18 mld. | |
-19,77% | 19,44 mld. | |
+13,72% | 13,83 mld. | |
+31,16% | 12,4 mld. | |
+9,19% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel AbCellera Biologics Inc. - Nasdaq
- Onderneming AbCellera Biologics Inc.